Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

Presentation TCT 2024

Where Does Interventional Cardiologist Fit in Advancing Interventional Treatment of Pulmonary Thromboembolism?

Presenter: Riyaz Bashir

October 28, 2024

Presentation TCT 2022

CTEPH? CTED? How Do We Make the Diagnosis?

Presenter: Riyaz Bashir

September 19, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

Presentation TCT 2022

A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study

Presenter: Riyaz Bashir

September 17, 2022

Presentation TCT 2019

A New Technology for Thrombolysis and Thromboectomy

Presenter: Riyaz Bashir

September 27, 2019

Presentation TCT 2019

Utility and Risks of Vena Cava Filters to Prevent PE

Presenter: Riyaz Bashir

September 26, 2019

News Industry News

Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism

July 29, 2019

News Industry News

Thrombolex, Inc. Announces 510(K) Premarket Notification Clearance Of The Bashir™ Endovascular Catheter And The Bashir N-X™ Endovascular Catheter For The Treatment Of Acute Venous And Arterial Thromboembolic Disorders

May 13, 2019

Presentation TCT 2018

Case #1 Conclusion: A Patient With Massive PE How Did We Treat?

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Vikas Aggarwal, Mahir Elder, Jay S. Giri, Gregory Piazza, Akhilesh K. Sista

September 23, 2018

Presentation TCT 2018

The Case for ECMO or Other RV Support as the Ideal Treatment for Massive PE!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Mahir Elder

September 23, 2018

Presentation TCT 2018

The Case for Surgical Therapy for Massive PE as the First-line Therapy!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Marisa Cevasco

September 23, 2018

Presentation TCT 2018

The Case for Catheter-based Therapy for Massive PE as the Principal Approach!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Akhilesh K. Sista

September 23, 2018

Presentation TCT 2018

Case #2 Introduction: A Patient With Massive PE How Should We Treat?

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Vikas Aggarwal, Mahir Elder, Jay S. Giri, Gregory Piazza, Akhilesh K. Sista

September 23, 2018

Presentation TCT 2018

Case #1 Conclusion: A Patient With Sub-Massive PE How Did We Treat?

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Vikas Aggarwal, Mahir Elder, Jay S. Giri, Gregory Piazza, Akhilesh K. Sista

September 23, 2018

Presentation TCT 2018

First Debate: Catheter-Directed Thrombolysis Should Be Reserved for Selected Submassive PE!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Jay S. Giri

September 23, 2018

Presentation TCT 2018

First Debate: Catheter-Directed Thrombolysis Should Be Used for All Submassive PE!

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson

September 23, 2018

Presentation TCT 2018

Case #1 Introduction: A Patient With Sub-Massive PE How Should We Treat?

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson, Vikas Aggarwal, Mahir Elder, Jay S. Giri, Gregory Piazza, Akhilesh K. Sista

September 23, 2018

Presentation TCT 2018

Acute Pulmonary Embolism: Risk Stratification, Treatment Alternatives, and Role of the PERT Team

Presenter: Riyaz Bashir, Kenneth Rosenfield, Victor F. Tapson

September 23, 2018

Advertisement

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Where Does Interventional Cardiologist Fit in Advancing Interventional Treatment of Pulmonary Thromboembolism?

CTEPH? CTED? How Do We Make the Diagnosis?

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study

A New Technology for Thrombolysis and Thromboectomy

Utility and Risks of Vena Cava Filters to Prevent PE

Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism

Thrombolex, Inc. Announces 510(K) Premarket Notification Clearance Of The Bashir™ Endovascular Catheter And The Bashir N-X™ Endovascular Catheter For The Treatment Of Acute Venous And Arterial Thromboembolic Disorders

Case #1 Conclusion: A Patient With Massive PE How Did We Treat?

The Case for ECMO or Other RV Support as the Ideal Treatment for Massive PE!

The Case for Surgical Therapy for Massive PE as the First-line Therapy!

The Case for Catheter-based Therapy for Massive PE as the Principal Approach!

Case #2 Introduction: A Patient With Massive PE How Should We Treat?

Case #1 Conclusion: A Patient With Sub-Massive PE How Did We Treat?

First Debate: Catheter-Directed Thrombolysis Should Be Reserved for Selected Submassive PE!

First Debate: Catheter-Directed Thrombolysis Should Be Used for All Submassive PE!

Case #1 Introduction: A Patient With Sub-Massive PE How Should We Treat?

Acute Pulmonary Embolism: Risk Stratification, Treatment Alternatives, and Role of the PERT Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content